Literature DB >> 3409560

Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparin.

A E Lee1, L A Rogers, R E Jeffery, J M Longcroft.   

Abstract

A murine mammary carcinoma, which had a high potential for metastasis to the lungs, was established in culture, and from the parent line several clonally derived variants were isolated, showing different characteristics including metastatic potential. C1, a high metastatic clone, and C2, a low one, were selected for further study. When tumour cells were injected s.c. the growth rates of the resulting tumours were higher when they developed from the parent line (P2) or C1 cells, than from C2 cells. The numbers of lung colonies seen following i.v. inoculation of tumour cells also varied, C2 cells yielding the lowest score. In vitro C1 cells were more efficient at aggregating platelets than C2, an effect reduced by the addition of heparin. In vivo heparin reduced the number of tumour cells arrested in the lungs after i.v. injection, and also the number lung colonies which subsequently became established. The number of metastases which developed following s.c. injection of tumour cells was also reduced by heparin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409560     DOI: 10.1007/bf01784377

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

Review 1.  The effect of heparin and warfarin on primary and metastatic tumors.

Authors:  R C Millar; A S Ketcham
Journal:  J Med       Date:  1974

2.  Antimetastatic effects associated with platelet reduction.

Authors:  G J Gasic; T B Gasic; C C Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

3.  Human platelet-tumor cell interactions vary with the tumor cell lines.

Authors:  A Camez; E Dupuy; S Bellucci; F Calvo; M C Bryckaert; G Tobelem
Journal:  Invasion Metastasis       Date:  1986

4.  A new mechanism for tumor induced platelet aggregation. Comparison with mechanisms shared by other tumor with possible pharmacologic strategy toward prevention of metastases.

Authors:  W A Lerner; E Pearlstein; C Ambrogio; S Karpatkin
Journal:  Int J Cancer       Date:  1983-04-15       Impact factor: 7.396

5.  Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.

Authors:  G J Gasic; T B Gasic; N Galanti; T Johnson; S Murphy
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Tumour-cell-induced platelet aggregation: studies with cloned metastatic and non-metastatic variants.

Authors:  M G Lampugnani; N Crawford
Journal:  Invasion Metastasis       Date:  1987

7.  Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential.

Authors:  G Grignani; L Pacchiarini; P Almasio; M Pagliarino; G Gamba; S C Rizzo; E Ascari
Journal:  Int J Cancer       Date:  1986-08-15       Impact factor: 7.396

Review 8.  'Seed and soil' revisited: mechanisms of site-specific metastasis.

Authors:  I R Hart
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.

Authors:  K V Honn
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

10.  Anticoagulants and experimental metastases-evaluation of antimetastatic effects in different model systems.

Authors:  B Maat; P Hilgard
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

View more
  3 in total

1.  In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors:  S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Reduction of metastasis in a murine mammary tumour model by heparin and polyinosinic-polycytidylic acid.

Authors:  A E Lee; L A Rogers; J M Longcroft; R E Jeffery
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

3.  Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?

Authors:  Mehmet Kucukoner; Abdurrahman Isikdogan; Muhammed Ali Kaplan; Ali Inal; S Zinciroglu; Murtaza Cit; Timucin Cil; Bilgehan Karadayi; Ahmet Dirier; Ismail Yildiz
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.